Evidence map›Paper›PMID 22509262›Full record

ArticlePloS one2012

Genes involved in systemic and arterial bed dependent atherosclerosis--Tampere Vascular study.

Mari Levula, Niku Oksala, Nina Airla, Rainer Zeitlin, Juha-Pekka Salenius, Otso Järvinen, Maarit Venermo, Teemu Partio, Jukka Saarinen, Taija Somppi and 11 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. The role of lactoferrin in atherosclerosis.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023
    Review
  11. Article
  12. Journal of clinical medicine · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Mari LevulaDepartment of Clinical Chemistry, Centre for Laboratory Medicine, Tampere University Hospital, and Medical School, University of Tampere, Tampere, Finland. mari@levula.fi
Niku Oksala
Nina Airla
Rainer Zeitlin
Juha-Pekka Salenius
Otso Järvinen
Maarit Venermo
Teemu Partio
Jukka Saarinen
Taija Somppi
VeliPekka Suominen
Jyrki Virkkunen
Juha Hautalahti
Reijo Laaksonen
Mika Kähönen
Ari Mennander
Leena Kytömäki
Juhani T Soini
Jyrki Parkkinen
Markku Pelto-Huikko
Terho Lehtimäki
Tampere University · FITampere University Hospital · FITurku Centre for Biotechnology · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtherosclerosis is a complex disease with hundreds of genes influencing its progression. In addition, the phenotype of the disease varies significantly depending on the arterial bed. METHODOLOGY/PRINCIPAL

findingsWe characterized the genes generally involved in human advanced atherosclerotic (AHA type V-VI) plaques in carotid and femoral arteries as well as aortas from 24 subjects of Tampere Vascular study and compared the results to non-atherosclerotic internal thoracic arteries (n=6) using genome-wide expression array and QRT-PCR. In addition we determined genes that were typical for each arterial plaque studied. To gain a comprehensive insight into the pathologic processes in the plaques we also analyzed pathways and gene sets dysregulated in this disease using gene set enrichment analysis (GSEA). According to the selection criteria used (>3.0 fold change and p-value <0.05), 235 genes were up-regulated and 68 genes down-regulated in the carotid plaques, 242 genes up-regulated and 116 down-regulated in the femoral plaques and 256 genes up-regulated and 49 genes down-regulated in the aortic plaques. Nine genes were found to be specifically induced predominantly in aortic plaques, e.g., lactoferrin, and three genes in femoral plaques, e.g., chondroadherin, whereas no gene was found to be specific for carotid plaques. In pathway analysis, a total of 28 pathways or gene sets were found to be significantly dysregulated in atherosclerotic plaques (false discovery rate [FDR] <0.25).

conclusionsThis study describes comprehensively the gene expression changes that generally prevail in human atherosclerotic plaques. In addition, site specific genes induced only in femoral or aortic plaques were found, reflecting that atherosclerotic process has unique features in different vascular beds.

Indexed as

Gene Expression ProfilingAgedArteriesCase-Control StudiesFemaleFinlandGenomicsHumansMaleOrgan SpecificityPlaque, Atherosclerotic

Identifiers

PMID22509262
PMCPMC3324479
OpenAlexW2044549516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.